Sobi appoints Lydia Abad-Franch as Head of R&D and Chief Medical Officer
Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) today announced the appointment of Lydia Abad-Franch, MD, MBA as Senior Vice President, Head of Research, Development and Medical Affairs (RDMA), and Chief Medical Officer. Abad-Franch has been in this role on an interim basis since June. “Lydia is both an accomplished leader in rare diseases and an esteemed practicing medical doctor,” said Guido Oelkers, CEO of Sobi. “In addition, she has deep knowledge of the Sobi business as she has been with us for almost four years. This makes her the ideal RDMA leader for us as we continue